Shares of Novavax Inc. NVAX, -11.41%, which is developing two...

First 65 Last

Share
Profile

Follow
vasilios

3,692 Posts.

353

22/01/20

12:10

Post #: 42511393
Share

Originally posted by Glitterati: ↑

Totally agree with you about this being a really exciting stock to be in. The rewards, should the trials go as expected, should be phenomenal IMO, given that this is truly ground breaking technology targeting a multi multi billion dollar market.

What's even more exciting is the fact that it has been derisked to such a large extent.

Think about it:-
- would Israeli biotech company NewPhase be ordering our nanoparticles if they didn't do what is purported by the company?
- FDA has already classified the MagSense as a breakthrough device enabling the company to fast track through to commercialisation; the submission to the FDA and the FDA confirming the breakthrough classification took all of 3 weeks - this in itself tells you something.
- the T20 is so heavily invested in this and maintaining their shareholdings to a large extent.
- toxicology testing has already been conducted and the results came back confirming that the technology is completely safe with no adverse effects.
- testing already successfully conducted on mice.

I'm not a trader, I'm an investor and I currently have my money, and a significant outlay at that, on 2 stocks only, IBX and IHL

Onwards and upwards....

These are my opinions only.... please DYOR and GLTAH......roll on in-human trials, lets get this show on the road!

Expand

Shares of Novavax Inc. NVAX, -11.41%, which is developing two late-stage vaccines for the flu and other infectious diseases, gained 36%. NanoViricides Inc. NNVC, +9.41%, a maker of nano-medicines for viral diseases, including swine and bird influenza, soared 74%. Aethlon Medical Inc.

Also, nanoparticles could be used to fight coronavirus.

IBX Price at posting: 3.4¢ Sentiment: Hold Disclosure: Held
10 Upvote

1 Great analysis

Reply